Garzan received her doctorate in organic chemistry from Michigan State University and her Master of Science in organic chemistry from Shiraz University. After completing her doctorate, she joined Professor Wipf’s group at the University of Pittsburgh working on a new class of STAT3 pathway inhibitors. In 2013, she joined Professor Garneau-Tsodikova’s group at the University of Kentucky College of Pharmacy, where she worked on the identification, synthesis, and SAR studies of compounds possessing activity in the low nanomolar range against an enzyme responsible for extensive drug resistance (XDR) in Mycobacterium tuberculosis. Garzan joined Southern Research in 2017 as an associate research chemist. She is currently working in the area of antiviral drug discovery in the Antiviral Drug Discovery and Development Center (AD3C), one of the Centers of Excellence for Translation Research (CETR). She is responsible for providing synthetic chemistry efforts of various target compounds as potential therapeutics for the treatment of Chikungunya virus (CHIKV). Garzan is co-author of 16 peer-reviewed scientific publications..